Novo Nordisk Begins New Study Testing Smaller Doses Of Blockbuster Wegovy – A Look At Some Key Highlights
The 450-person late-stage study began on August 12 and is being conducted across 62 locations in the U.S.…
Novo Nordisk’s denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase 3 hemophilia A FRONTIER extension study at ISTH 2026
Presented interim FRONTIER4 data evaluate the long-term safety and efficacy of investigational denecimig across once-weekly, once-every-two-weeks, and once-monthly…
A Weight-Loss Rival Just Crashed 23%. Why That’s Great News for Eli Lilly and Novo Nordisk.
Key Points Zealand Pharma reported a high drop-out rate in a phase III trial of Survodutide, due to…
A Weight-Loss Rival Just Crashed 23%. Why That’s Great News for Eli Lilly and Novo Nordisk.
The GLP weight-loss space has become increasingly competitive as new players have entered what many believe is a…
Novo Nordisk Highlights New Wegovy Pill Data
Novo Nordisk A/S (NYSE:NVO) presented new analyses from its phase 3 OASIS 4 clinical trial at the European…
Joint Declaration of Intent Between Canada and Greenland on Critical Minerals and Energy Cooperation
JOINT DECLARATION OF INTENT between The DEPARTMENT OF NATURAL RESOURCES OF CANADA and The MINISTRY OF BUSINESS, MINERAL…
Participants March in 15th Warsaw Uprising Remembrance in Białystok Streets
Participants gathered in Białystok to honor the soldiers of the post-war resistance during the 15th Warsaw Uprising Remembrance.…
Strengthening International Cooperation within ATHENA: UMCS Study Visit to VILNIUS TECH – January – 2026 – News – ATHENA UMCS
From November 17–21, 2025, UMCS administrative staff took part in a study visit to VILNIUS TECH in Vilnius,…